Skip to main content

Maryland State Medical Society 選用 PRA Health Sciences 提供遠程患者監測和遠程醫療服務

Written by Customer Service on . Posted in Public Companies.

北卡羅來納州羅利，以及巴爾的摩, April 23, 2021 (GLOBE NEWSWIRE) — PRA Health Sciences (NASDAQ: PRAH) 和 Maryland State Medical Society (MedChi) 今天宣佈 PRA Health Sciences 公司旗下的 Care Innovations 獲 MedChi 選為遠程患者監測、遠程醫療，以及數碼健康服務的首選供應商，以服務由 22,000 多位持牌醫生組成的網絡，涵蓋超過 50 個醫療專科。馬里蘭州醫生現可運用值得信賴的供應商，快速部署一個安全且符合私隱規定的系統，以遠程進行患者護理，包括常規就診和慢性疾病管理。

MedChi 行政總裁 Gene Ransom 說：「現在是採用 RPM 管理患者護理的時候了。疫情已證實遠程患者監測的臨床和經濟效益，而醫生正在尋找合適的供應商來支援這個長遠的虛擬模式。MedChi 欣然協助醫生快速選擇一個全面的供應商，並讓患者更易使用這些重要的服務。」

遠程患者監測是醫療護理的重要組成部分，可促進更理想的患者結果和更高的患者滿意度。透過自動和遠程提取醫療資訊，RPM 可提供全面的患者為主護理，特別是針對老年人和高風險患者。在現今的疫情環境下，RPM 可為安在家中的患者評估其健康資訊，協助患者避免接觸 2019 冠狀病毒病，同時減少急症室就診和住院數量。

選擇 Care Innovations 的醫生將可獲得針對醫生和患者的技術，包括遠程患者監測平台、Health Harmony 流動應用程式、由護士領導的協調中心和連接互聯網的裝置，如血壓計手袖、脈搏血氧飽和度分析儀和血糖儀。患者可使用這些醫療裝置和流動應用程式在家自行管理護理，而醫生則可遠程監測數據。此外，醫生可以選擇每月護理管理服務，這允許他們為符合要求的患者就 Medicare CPT RPM 代碼下的服務收費。

PRA Health Sciences 高級副總裁兼 Care Innovations 總裁 Randy Swanson 說：「遠程患者監測和遠程醫療服務可為醫生提供一種創新方式，幾乎即時監控患者的健康情況，但無須離家或受到時間限制。PRA 的數碼健康解決方案提供基礎架構、技術和付款人報銷計劃，以支援醫生的執業要求和患者的醫療需要。」

如欲了解更多資訊或立即登記使用這些服務，馬里蘭州醫生可以瀏覽 CareInnovations.com 或 MedChi 網頁。

關於 PRA Health Sciences

PRA Health Sciences 是按收入計算的全球領先環球合約研究組織之一，為生物技術和製藥業提供承包臨床開發及數據解決方案服務。PRA 的全球臨床開發平台包括位於北美、歐洲、亞洲、拉丁美洲、非洲、澳洲及中東等 75 多個辦事處，在全球各地擁有超過 19,000 名員工。自 2000 年以來，PRA 已在世界各地參與約 4,000 項臨床試驗。此外，PRA 還參與了不少關鍵或支持性試驗，促成美國食品及藥物管理局或國際監管機構批准超過 95 種產品。如欲進一步了解 PRA，請瀏覽 www.prahs.com。

投資者查詢：InvestorRelations@prahs.com

傳媒查詢：傳訊及公共關係高級總監 Laurie Hurst
電郵：hurstlaurie@prahs.com | 電話：+1 (919) 786-8435

關於 Maryland State Medical Society

Maryland State Medical Society (MedChi) 是馬里蘭州醫生的非牟利會員協會。它是馬里蘭州最大的醫生組織。MedChi 的使命是成為馬里蘭州醫生、其患者及馬里蘭州公共衛生的主要倡導者和資源。如欲了解更多資訊，請瀏覽 www.medchi.org。

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.